The present invention relates to enzyme inhibitors. More specifically, the present invention relates to ligand-directed covalent modification of proteins; method of designing same; pharmaceutical formulation of same; and method of use.
申请公布号
CA2785738(A1)
申请公布日期
2011.07.07
申请号
CA20102785738
申请日期
2010.12.30
申请人
AVILA THERAPEUTICS, INC.
发明人
PETTER, RUSSELL C.;JEWELL, CHARLES F.;LEE, KWANGHO;MEDIKONDA, ARAVIND PRASAD;NIU, DEQIANG;QIAO, LIXIN;SINGH, JUSWINDER;ZHU, ZHENDONG
